SKSergej Kudruk

Sergej Kudruk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sergej Kudruk has a total of 175 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Determining Composition–Structure–Property Relationships in Quaternary Perovskitoids Through Megalibraries

    by Olivier J. G. L. Chevalier, Sachin P. Kulkarni, Jarod Beights, Yichen Li, Sergej Kudruk, Allen X. Guo, Jun Li, Koray Aydin, Chris Wolverton, Chad A. Mirkin

    Understanding how composition governs structure and function is essential for designing functional materials, however, establishing these relationships remains prohibitively slow for materials with massive and tunable compositional spaces, such as Bi and Sb‐based perovskitoids. Here, a novel megalibrary‐based synthetic methodology has been developed and used to rapidly identify and characterize quaternary perovskite derivatives across an expansive compositional space. Parylene templates were used to synthesize one million compositionally distinct, positionally encoded Cs 3 Sb 2−x Bi x Br 9−y I y microcrystals on 2 × 2 cm 2 chips with 20 µm periodicity. These megalibraries enabled the systematic investigation of structural and optoelectronic evolution across this compositional space using micro‐area x‐ray diffraction, position‐resolved absorbance spectroscopy, scanning electron microscopy, and confocal fluorescence microscopy. An unusual non‐monotonic bandgap shift was observed with increasing Br content, reaching a minimum at 33% Br. This behavior is attributed to the formation of halide‐segregated heterostructures, consisting of low‐dimensional, I‐rich shells surrounding Br‐rich layered cores. Phase separation was most pronounced in Sb‐rich compositions, which were found to stabilize heterostructure formation. This study demonstrates how megalibraries enable the simultaneous evaluation of key optoelectronic parameters, including bandgap and phase purity, revealing complex, composition‐dependent structure‐function relationships in perovskitoids and providing a versatile platform for accelerating the discovery of optoelectronic‐relevant materials.

  • Open Access

    E7 11-19 placement and orientation dictate CD8 + T cell response in structurally defined spherical nucleic acid vaccines

    by Jeongmin Hwang, Tonatiuh A. Ocampo, Vinzenz Mayer, Janice Kang, Krishna S. Paranandi, Young Jun Kim, Zhenyu Han, John P. Cavaliere, Sergej Kudruk, Jochen H. Lorch, et al.

    To develop effective nanostructured immunotherapeutics, identifying structural parameters that maximize immune response is essential. Spherical nucleic acids (SNAs) provide a modular platform for coordinated antigen-adjuvant delivery, where subtle structural differences can markedly influence potency. Herein, three SNAs were designed with HLA-A2–restricted HPV16 E7 11-19 peptide and CpG adjuvant, nearly identical in composition but differing in antigen presentation. All enhanced dendritic cell activation and CD8 + T cell cytotoxicity in primary human cells compared to peptide-CpG admixture; however, one variant, N-HSNA, elicited the strongest response, inducing ~8-fold higher interferon-γ secretion and ~2.5-fold greater cytotoxicity. In tumor-bearing AAD mice, N-HSNA reduced tumor burden by ~3.5-fold, prolonged survival, and expanded CD8 + T cells. Transcriptomic profiling revealed up-regulation of activation genes and suppression of exhaustion markers. In patient-derived HPV + head and neck cancer spheroids, N-HSNA enhanced cytotoxicity ~2.5-fold, establishing antigen placement and orientation as key parameters for translational cancer immunotherapy.


  • Open Access

    Structural immunotherapy: Harnessing chemical design to build powerful next-generation therapeutics

    by Michelle H. Teplensky, Julianna N. Bourgeois, Sergej Kudruk, Sarah Hurst Petrosko, Chad A. Mirkin

    Structural immunotherapy relies on the structural features of immunotherapeutics in addition to component identity to influence biodistribution, intra- or extracellular localization, target engagement, and processing kinetics. This strategy is poised to redefine how immunotherapeutics mobilize immunity against disease and transform our ability to harness structure–function relationships to enhance clinical outcomes.


  • Top Cited Papers

    33 Unresolved Questions in Nanoscience and Nanotechnology

    by Chad A. Mirkin, Sarah Hurst Petrosko, Natalie Artzi, Koray Aydin, Austin Biaggne, C. Jeffrey Brinker, Katherine E. Bujold, Y. Charles Cao, Rachel R. Chan, Chaojian Chen, et al.

    Significant advances in science and engineering often emerge at the intersections of disciplines. Nanoscience and nanotechnology are inherently interdisciplinary, uniting researchers from chemistry, physics, biology, medicine, materials science, and engineering. This convergence has fostered novel ways of thinking and enabled the development of materials, tools, and technologies that have transformed both basic and applied research, as well as how we address critical societal challenges. In this Nano Focus, we pose and explore 33 questions whose answers could profoundly impact fields such as energy, electronics, the environment, optics, and medicine. These questions highlight the need for deeper foundational understanding, improved tools and techniques, and innovative applications─each with significant societal relevance. Together, they represent a global call-to-action for the scientific community.


  • Open Access

    Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy

    by Sergej Kudruk, Connor M. Forsyth, Michelle Z. Dion, Jenny K. Hedlund Orbeck, Jingqin Luo, Robyn S. Klein, Albert H. Kim, Amy B. Heimberger, Chad A. Mirkin, Alexander H. Stegh, et al.

    Integrating multimodal neuro- and nanotechnology-enabled precision immunotherapies with extant systemic immunotherapies may finally provide a significant breakthrough for combatting glioblastoma (GBM). The potency of this approach lies in its ability to train the immune system to efficiently identify and eradicate cancer cells, thereby creating anti-tumor immune memory while minimizing multi-mechanistic immune suppression. A critical aspect of these therapies is the controlled, spatiotemporal delivery of structurally defined nanotherapeutics into the GBM tumor microenvironment (TME). Architectures such as spherical nucleic acids or poly(beta-amino ester)/dendrimer-based nanoparticles have shown promising results in preclinical models due to their multivalency and abilities to activate antigen-presenting cells and prime antigen-specific T cells. These nanostructures also permit systematic variation to optimize their distribution, TME accumulation, cellular uptake, and overall immunostimulatory effects. Delving deeper into the relationships between nanotherapeutic structures and their performance will accelerate nano-drug development and pave the way for the rapid clinical translation of advanced nanomedicines. In addition, the efficacy of nanotechnology-based immunotherapies may be enhanced when integrated with emerging precision surgical techniques, such as laser interstitial thermal therapy, and when combined with systemic immunotherapies, particularly inhibitors of immune-mediated checkpoints and immunosuppressive adenosine signaling. In this perspective, we highlight the potential of emerging treatment modalities, combining advances in biomedical engineering and neurotechnology development with existing immunotherapies to overcome treatment resistance and transform the management of GBM. We conclude with a call to action for researchers to leverage these technologies and accelerate their translation into the clinic.


  • Open Access

    Enhancing Endosomal Escape and Gene Regulation Activity for Spherical Nucleic Acids

    by Jungsoo Park, Michael Evangelopoulos, Matthew Kuo Vasher, Sergej Kudruk, Namrata Ramani, Vinzenz Mayer, Alexander Carlos Solivan, Andrew Lee, Chad Alexander Mirkin

    The therapeutic potential of small interfering RNAs (siRNAs) is limited by their poor stability and low cellular uptake. When formulated as spherical nucleic acids (SNAs), siRNAs are resistant to nuclease degradation and enter cells without transfection agents with enhanced activity compared to their linear counterparts; however, the gene silencing activity of SNAs is limited by endosomal entrapment, a problem that impacts many siRNA‐based nanoparticle constructs. To increase cytosolic delivery, SNAs are formulated using calcium chloride (CaCl2) instead of the conventionally used sodium chloride (NaCl). The divalent calcium (Ca2+) ions remain associated with the multivalent SNA and have a higher affinity for SNAs compared to their linear counterparts. Importantly, confocal microscopy studies show a 22% decrease in the accumulation of CaCl2‐salted SNAs within the late endosomes compared to NaCl‐salted SNAs, indicating increased cytosolic delivery. Consistent with this finding, CaCl2‐salted SNAs comprised of siRNA and antisense DNA all exhibit enhanced gene silencing activity (up to 20‐fold), compared to NaCl‐salted SNAs regardless of sequence or cell line (U87‐MG and SK‐OV‐3) studied. Moreover, CaCl2‐salted SNA‐based forced intercalation probes show improved cytosolic mRNA detection.


  • Transferrin Aptamers Increase the In Vivo Blood–Brain Barrier Targeting of Protein Spherical Nucleic Acids

    by Caroline D. Kusmierz, Cassandra E. Callmann, Sergej Kudruk, Max E. Distler, Chad A. Mirkin

    The systemic delivery of exogenous proteins to cells within the brain and central nervous system (CNS) is challenging due to the selective impermeability of the blood-brain barrier (BBB). Herein, we hypothesized that protein delivery to the brain could be improved via functionalization with DNA aptamers designed to bind transferrin (TfR) receptors present on the endothelial cells that line the BBB. Using β-galactosidase (β-Gal) as a model protein, we synthesized protein spherical nucleic acids (ProSNAs) comprised of β-Gal decorated with TfR aptamers (Transferrin-ProSNAs). The TfR aptamer motif significantly increases the accumulation of β-Gal in brain tissue in vivo following intravenous injection over both the native protein and ProSNAs containing nontargeting DNA sequences. Furthermore, the widespread distribution of β-Gal throughout the brain is only observed for Transferrin-ProSNAs. Together, this work shows that the SNA architecture can be used to selectively deliver protein cargo to the brain and CNS if the appropriate aptamer sequence is employed as the DNA shell. Moreover, this highlights the importance of DNA sequence design and provides a potential new avenue for designing highly targeted protein delivery systems by combining the power of DNA aptamers together with the SNA platform.


  • An Imidazolium‐Based Lipid Analogue as a Gene Transfer Agent

    by Tiffany O. Paulisch, Steffen Bornemann, Marius Herzog, Sergej Kudruk, Lena Roling, Anna Livia Linard Matos, Hans‐Joachim Galla, Volker Gerke, Roland Winter, Frank Glorius

    A dicationic imidazolium salt is described and investigated towards its application for gene transfer. The polar head group and the long alkyl chains in the backbone contribute to a lipid‐like behavior, while an alkyl ammonium group provides the ability for crucial electrostatic interaction for the transfection process. Detailed biophysical studies regarding its impact on biological membrane models and the propensity of vesicle fusion are presented. Fluorescence spectroscopy, atomic force microscopy and confocal fluorescence microscopy show that the imidazolium salt leads to negligible changes in lipid packing, while displaying distinct vesicle fusion properties. Cell culture experiments reveal that mixed liposomes containing the novel imidazolium salt can serve as plasmid DNA delivery vehicles. In contrast, a structurally similar imidazolium salt without a second positive charge showed no ability to support DNA transfection into cultured cells. Thus, we introduce a novel and variable structural motif for cationic lipids, expanding the field of lipofection agents.


  • Open Access

    Membrane Binding Promotes Annexin A2 Oligomerization

    by Anna Lívia Linard Matos, Sergej Kudruk, Johanna Moratz, Milena Heflik, David Grill, Bart Jan Ravoo, Volker Gerke

    Annexin A2 (AnxA2) is a cytosolic Ca2+ regulated membrane binding protein that can induce lipid domain formation and plays a role in exocytosis and endocytosis. To better understand the mode of annexin-membrane interaction, we analyzed membrane-bound AnxA2 assemblies by employing a novel 3-armed chemical crosslinker and specific AnxA2 mutant proteins. Our data show that AnxA2 forms crosslinkable oligomers upon binding to membranes containing negatively charged phospholipids. AnxA2 mutants with amino acid substitutions in residues predicted to be involved in lateral protein–protein interaction show compromised oligomer formation, albeit still being capable of binding to negatively charged membranes in the presence of Ca2+. These results suggest that lateral protein–protein interactions are involved in the formation of AnxA2 clusters on a biological membrane.


  • Open Access

    Controlled Cellular Delivery of Amphiphilic Cargo by Redox‐Responsive Nanocontainers

    by Wilke C. de Vries, Sergej Kudruk, David Grill, Maximilian Niehues, Anna Livia Linard Matos, Maren Wissing, Armido Studer, Volker Gerke, Bart Jan Ravoo

    The specific transport of amphiphilic compounds such as fluorescently labeled phospholipids into cells is a prerequisite for the analysis of highly dynamic cellular processes involving these molecules, e.g., the intracellular distribution and metabolism of phospholipids. However, cellular delivery remains a challenge as it should not affect the physiological integrity and morphology of the cell membrane. To address this, polymer nanocontainers based on redox‐responsive cyclodextrin (CD) amphiphiles are prepared, and their potential to deliver fluorescently labeled phospholipids to intracellular membrane compartments is analyzed. It is shown that mixtures of reductively degradable cyclodextrin amphiphiles and different phospholipids form liposome‐like vesicles (CD–lipid vesicles, CSSLV) with a homogeneous distribution of each lipid. Host–guest‐mediated self‐assembly of a cystamine‐crosslinked polymer shell on these CSSLV produces polymer‐shelled liposomal vesicles (PSSCSSLV) with the unique feature of a redox‐sensitive CSSLV core and reductively degradable polymer shell. PSSCSSLV show high stability and a redox‐sensitive release of the amphiphilic cargo. Live cell experiments reveal that the novel PSSCSSLV are readily internalized by primary human endothelial cells and that the reductive microenvironment of the cells' endosomes triggers the release of the amphiphilic cargo into the cytosol. Thus, PSSCSSLV represent a highly efficient system to transport lipid‐like amphiphilic cargo into the intracellular environment.